1. Home
  2. Labeler Index
  3. Obagi Cosmeceuticals Llc
  4. 62032-413
  5. NDC Package Code: 62032-413-20 Tretinoin

NDC Package 62032-413-20 Tretinoin

Gel Topical - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
62032-413-20
Package Description:
20 g in 1 TUBE
Product Code:
62032-413
Proprietary Name:
Tretinoin
Non-Proprietary Name:
Tretinoin
Substance Name:
Tretinoin
Usage Information:
This medication is used to treat acne. It may decrease the number and severity of acne pimples and promote quick healing of pimples that do develop. Tretinoin belongs to a class of medications called retinoids. It works by affecting the growth of skin cells.
11-Digit NDC Billing Format:
62032041320
NDC to RxNorm Crosswalk:
  • RxCUI: 245723 - tretinoin 0.05 % Topical Gel
  • RxCUI: 245723 - tretinoin 0.0005 MG/MG Topical Gel
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Obagi Cosmeceuticals Llc
    Dosage Form:
    Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
    Administration Route(s):
  • Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
    • Active Ingredient(s):
  • TRETINOIN .05 g/100g
    • Pharmacologic Class(es):
  • Retinoid - [EPC] (Established Pharmacologic Class)
  • Retinoids - [CS]
    • Sample Package:
    No
    FDA Application Number:
    NDA022070
    Marketing Category:
    NDA AUTHORIZED GENERIC - A product marketed as a "generic" drug under an approved New Drug Application (NDA), rather than an Abbreviated New Drug Application (ANDA),.
    Start Marketing Date:
    06-19-2014
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 62032-413-20?

    The NDC Packaged Code 62032-413-20 is assigned to a package of 20 g in 1 tube of Tretinoin, a human prescription drug labeled by Obagi Cosmeceuticals Llc. The product's dosage form is gel and is administered via topical form.

    Is NDC 62032-413 included in the NDC Directory?

    Yes, Tretinoin with product code 62032-413 is active and included in the NDC Directory. The product was first marketed by Obagi Cosmeceuticals Llc on June 19, 2014 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 62032-413-20?

    The 11-digit format is 62032041320. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-262032-413-205-4-262032-0413-20